151
|
Gnatiuc L, Herrington WG, Halsey J, Tuomilehto J, Fang X, Kim HC, De Bacquer D, Dobson AJ, Criqui MH, Jacobs DR, Leon DA, Peters SAE, Ueshima H, Sherliker P, Peto R, Collins R, Huxley RR, Emberson JR, Woodward M, Lewington S, Aoki N, Arima H, Arnesen E, Aromaa A, Assmann G, Bachman DL, Baigent C, Bartholomew H, Benetos A, Bengtsson C, Bennett D, Björkelund C, Blackburn H, Bonaa K, Boyle E, Broadhurst R, Carstensen J, Chambless L, Chen Z, Chew SK, Clarke R, Cox C, Curb JD, D'Agostino R, Date C, Davey Smith G, De Backer G, Dhaliwal SS, Duan XF, Ducimetiere P, Duffy S, Eliassen H, Elwood P, Empana J, Garcia-Palmieri MH, Gazes P, Giles GG, Gillis C, Goldbourt U, Gu DF, Guasch-Ferre M, Guize L, Haheim L, Hart C, Hashimoto S, Hashimoto T, Heng D, Hjermann I, Ho SC, Hobbs M, Hole D, Holme I, Horibe H, Hozawa A, Hu F, Hughes K, Iida M, Imai K, Imai Y, Iso H, Jackson R, Jamrozik K, Jee SH, Jensen G, Jiang CQ, Johansen NB, Jorgensen T, Jousilahti P, Kagaya M, Keil J, Keller J, Kim IS, Kita Y, Kitamura A, Kiyohara Y, Knekt P, Knuiman M, Kornitzer M, Kromhout D, Kronmal R, Lam TH, Law M, Lee J, Leren P, Levy D, Li YH, Lissner L, Luepker R, Luszcz M, MacMahon S, Maegawa H, Marmot M, Matsutani Y, Meade T, Morris J, Morris R, Murayama T, Naito Y, Nakachi K, Nakamura M, Nakayama T, Neaton J, Nietert PJ, Nishimoto Y, Norton R, Nozaki A, Ohkubo T, Okayama A, Pan WH, Puska P, Qizilbash N, Reunanen A, Rimm E, Rodgers A, Saitoh S, Sakata K, Sato S, Schnohr P, Schulte H, Selmer R, Sharp D, Shifu X, Shimamoto K, Shipley M, Silbershatz H, Sorlie P, Sritara P, Suh I, Sutherland SE, Sweetnam P, Tamakoshi A, Tanaka H, Thomsen T, Tominaga S, Tomita M, Törnberg S, Tunstall-Pedoe H, Tverdal A, Ueshima H, Vartiainen E, Wald N, Wannamethee SG, Welborn TA, Whincup P, Whitlock G, Willett W, Woo J, Wu ZL, Yao SX, Yarnell J, Yokoyama T, Yoshiike N, Zhang XH. Sex-specific relevance of diabetes to occlusive vascular and other mortality: a collaborative meta-analysis of individual data from 980 793 adults from 68 prospective studies. Lancet Diabetes Endocrinol 2018; 6:538-546. [PMID: 29752194 PMCID: PMC6008496 DOI: 10.1016/s2213-8587(18)30079-2] [Citation(s) in RCA: 129] [Impact Index Per Article: 21.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/15/2017] [Revised: 02/20/2018] [Accepted: 02/26/2018] [Indexed: 01/06/2023]
Abstract
BACKGROUND Several studies have shown that diabetes confers a higher relative risk of vascular mortality among women than among men, but whether this increased relative risk in women exists across age groups and within defined levels of other risk factors is uncertain. We aimed to determine whether differences in established risk factors, such as blood pressure, BMI, smoking, and cholesterol, explain the higher relative risks of vascular mortality among women than among men. METHODS In our meta-analysis, we obtained individual participant-level data from studies included in the Prospective Studies Collaboration and the Asia Pacific Cohort Studies Collaboration that had obtained baseline information on age, sex, diabetes, total cholesterol, blood pressure, tobacco use, height, and weight. Data on causes of death were obtained from medical death certificates. We used Cox regression models to assess the relevance of diabetes (any type) to occlusive vascular mortality (ischaemic heart disease, ischaemic stroke, or other atherosclerotic deaths) by age, sex, and other major vascular risk factors, and to assess whether the associations of blood pressure, total cholesterol, and body-mass index (BMI) to occlusive vascular mortality are modified by diabetes. RESULTS Individual participant-level data were analysed from 980 793 adults. During 9·8 million person-years of follow-up, among participants aged between 35 and 89 years, 19 686 (25·6%) of 76 965 deaths were attributed to occlusive vascular disease. After controlling for major vascular risk factors, diabetes roughly doubled occlusive vascular mortality risk among men (death rate ratio [RR] 2·10, 95% CI 1·97-2·24) and tripled risk among women (3·00, 2·71-3·33; χ2 test for heterogeneity p<0·0001). For both sexes combined, the occlusive vascular death RRs were higher in younger individuals (aged 35-59 years: 2·60, 2·30-2·94) than in older individuals (aged 70-89 years: 2·01, 1·85-2·19; p=0·0001 for trend across age groups), and, across age groups, the death RRs were higher among women than among men. Therefore, women aged 35-59 years had the highest death RR across all age and sex groups (5·55, 4·15-7·44). However, since underlying confounder-adjusted occlusive vascular mortality rates at any age were higher in men than in women, the adjusted absolute excess occlusive vascular mortality associated with diabetes was similar for men and women. At ages 35-59 years, the excess absolute risk was 0·05% (95% CI 0·03-0·07) per year in women compared with 0·08% (0·05-0·10) per year in men; the corresponding excess at ages 70-89 years was 1·08% (0·84-1·32) per year in women and 0·91% (0·77-1·05) per year in men. Total cholesterol, blood pressure, and BMI each showed continuous log-linear associations with occlusive vascular mortality that were similar among individuals with and without diabetes across both sexes. INTERPRETATION Independent of other major vascular risk factors, diabetes substantially increased vascular risk in both men and women. Lifestyle changes to reduce smoking and obesity and use of cost-effective drugs that target major vascular risks (eg, statins and antihypertensive drugs) are important in both men and women with diabetes, but might not reduce the relative excess risk of occlusive vascular disease in women with diabetes, which remains unexplained. FUNDING UK Medical Research Council, British Heart Foundation, Cancer Research UK, European Union BIOMED programme, and National Institute on Aging (US National Institutes of Health).
Collapse
|
152
|
Odagaki N, Ishihara Y, Wang Z, Ei Hsu Hlaing E, Nakamura M, Hoshijima M, Hayano S, Kawanabe N, Kamioka H. Role of Osteocyte-PDL Crosstalk in Tooth Movement via SOST/Sclerostin. J Dent Res 2018; 97:1374-1382. [PMID: 29863952 DOI: 10.1177/0022034518771331] [Citation(s) in RCA: 41] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023] Open
Abstract
Sclerostin (Scl) negatively regulates bone formation and favors bone resorption. Osteocytes, the cells responsible for mechanosensing, are known as the primary source of Scl and are a key regulator of bone remodeling through the induction of receptor activator of NF-κB ligand (RANKL). However, the spatiotemporal patterns of Scl in response to mechanical stimuli and their regulatory mechanisms remain unknown. We investigated the regulatory dynamics of the SOST/Scl expression generated by orthodontic tooth movement (OTM) in vivo and in vitro. In 8-wk-old male mice, coil springs were used to move the first molar mesially for 0, 1, 5, or 10 d. A regional histogram and the distribution patterns of the Scl expression showed that the Scl expression in the alveolar bone was increased on the compression side and peaked on day 5, with a gradual increase in the degree of significance. On day 10, the expression around the periodontal ligament (PDL)-alveolar bone boundary returned to the control level. Conversely, the expression of Scl on the tension side was only significantly decreased on day 1. Compressive force biphasically modulated the SOST/Scl expression in the isolated human PDL and thereby upregulated osteocytic SOST via paracrine activation in an osteocyte-PDL co-culture system designed to mimic OTM. This system did not affect the RANKL or OPG expression in osteocytes, suggesting that the bone resorption pathways are acted upon in a PDL-dependent and osteocyte-independent manner through RANKL/OPG signaling. Moreover, sclerostin neutralizing antibody significantly attenuated the upregulation of SOST that was induced by compressive force. In conclusion, our results provide evidence to support that factors secreted by the PDL, including SOST/Scl, control alveolar bone remodeling through osteocytic SOST/Scl in OTM.
Collapse
Affiliation(s)
- N Odagaki
- 1 Department of Orthodontics, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
| | - Y Ishihara
- 2 Department of Orthodontics, Okayama University Hospital, Okayama, Japan
| | - Z Wang
- 1 Department of Orthodontics, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
| | - E Ei Hsu Hlaing
- 1 Department of Orthodontics, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
| | - M Nakamura
- 2 Department of Orthodontics, Okayama University Hospital, Okayama, Japan
| | - M Hoshijima
- 1 Department of Orthodontics, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
| | - S Hayano
- 1 Department of Orthodontics, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
| | - N Kawanabe
- 1 Department of Orthodontics, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
| | - H Kamioka
- 1 Department of Orthodontics, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
| |
Collapse
|
153
|
Shindo Y, Yuki S, Yagisawa M, Kawamoto Y, Tsuji Y, Hatanaka K, Kobayashi Y, Kajiura S, Ishiguro A, Honda T, Dazai M, Eto K, Nakamura M, Koike M, Ota S, Sato A, Kato K, Ueda A, Fukunaga A, Sekiguchi M, Sakata Y, Komatsu Y. HGCSG1503: A retrospective cohort study evaluating the safety and efficacy of TAS-102 in patients with metastatic colorectal cancer: Analysis of cases of prior regorafenib. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy151.257] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
154
|
Takahashi M, Munemoto Y, Nakamura M, Kotaka M, Kuroda H, Kato T, Minagawa N, Noura S, Fukunaga M, Kuramochi H, Touyama T, Takahashi T, Akagi Y, Satake H, Kurosawa S, Miura T, Mishima H, Sakamoto J, Oba K, Nagata N. SAPPHIRE: A randomized phase II study of oxaliplatin discontinuation after 6 cycles of mFOLFOX6 + panitumumab therapy in patients with colorectal cancer: Final analysis of efficacy and safety results. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy150.010] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
155
|
Nakamura M, Komatsu Y, Muranaka T, Yagisawa M, Kawamoto Y, Nakatsumi H, Yuki S, Saiki T, Ishiguro A, Tateyama M, Kobayashi Y, Miyagishima T, Takahata T, Sato A, Dazai M, Okuda H, Fujikawa K, Eto K, Muto S, Hatanaka K, Amano T, Sakata Y. HGCSG 1301: A Multicenter, Double-Blind, Randomized control phase II trial comparing Hange-shashin-to versus placebo to prevent diarrhea in patients with metastatic colorectal cancer under IRIS/Bev second-line treatment. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy151.225] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
156
|
Takeuchi S, Yoshino T, Yamanaka T, Kotaka M, Manaka D, Eto T, Hasegawa J, Takagane A, Nakamura M, Kato T, Munemoto Y, Bando H, Taniguchi H, Gamoh M, Shiozawa M, Saji S, Maehara Y, Mizushima T, Ohtsu A, Mori M. Long-term effect of peripheral sensory neuropathy (PSN) of 3 or 6 months oxaliplatin-based adjuvant chemotherapy for stage III colon cancer: ACHIEVE as part of the IDEA collaboration. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy149.027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
157
|
Kato T, Satake H, Oba K, Kagawa Y, Yasui H, Nakamura M, Watanabe T, Matsumoto T, Hirata K, Muro K, Komatsu Y, Yoshino T, Yamazaki K, Mishima H, Kotaka M, Tsuji A, Kakeji Y, Oki E, Nagata N, Sakamoto J. Multicenter phase Ib/II study of biweekly TAS-102 with bevacizumab combination for patients with metastatic colorectal cancer refractory to standard therapies (BiTS study) - Trial in progress. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy151.293] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
158
|
Kajimoto R, Nakamura M, Inamura Y, Kamazawa K, Ikeuchi K, Iida K, Ishikado M, Murai N, Kira H, Nakatani T, Ohira-Kawamura S, Takahashi R, Kubo N, Kambara W, Nakajima K, Aizawa K. Status report of the chopper spectrometer 4SEASONS. ACTA ACUST UNITED AC 2018. [DOI: 10.1088/1742-6596/1021/1/012030] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
159
|
Tsuji A, Nakamura M, Watanabe T, Manaka D, Matsuoka H, Kataoka M, Takeuchi M, Ichikawa W, Fujii M. Phase II study of third-line panitumumab rechallenge in patients with metastatic wild-type KRAS colorectal cancer who achieved a clinical benefit in response to first-line panitumumab plus chemotherapy. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy151.242] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
160
|
Yuki S, Komatsu Y, Kawamoto Y, Nakatsumi H, Takahashi N, Shichinohe T, Okuda H, Ishiguro A, Harada K, Iwanaga I, Hatanaka K, Oomori K, Nakamura M, Senmaru N, Iwai K, Koike M, Shinohara T, Miyashita K, Ito Y, Taketomi A, Hirano S, Sakamoto N. NORTH/HGCSG1003: A phase II study evaluating the safety and efficacy of FOLFOX as adjuvant chemotherapy for patients with stage III colon cancer: Comparison with medical oncologists and surgeons. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy151.222] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
161
|
Ioka T, Sakai D, Wada H, Eguchi H, Yanagihara K, Satake H, Shimizu J, Kanai M, Hashimoto K, Ajiki T, Nakamura M, Takeda Y, Yoshimura K, Hatano E, Nagano H. The feasibility study of short hydration with oral rehydration therapy in chemotherapy with cisplatin plus gemcitabine for biliary tract cancer (KHBO-1302). Ann Oncol 2018. [DOI: 10.1093/annonc/mdy151.118] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
162
|
Agafonova N, Alexandrov A, Anokhina A, Aoki S, Ariga A, Ariga T, Bertolin A, Bozza C, Brugnera R, Buonaura A, Buontempo S, Chernyavskiy M, Chukanov A, Consiglio L, D'Ambrosio N, De Lellis G, De Serio M, Del Amo Sanchez P, Di Crescenzo A, Di Ferdinando D, Di Marco N, Dmitrievsky S, Dracos M, Duchesneau D, Dusini S, Dzhatdoev T, Ebert J, Ereditato A, Favier J, Fini RA, Fornari F, Fukuda T, Galati G, Garfagnini A, Gentile V, Goldberg J, Gorbunov S, Gornushkin Y, Grella G, Guler AM, Gustavino C, Hagner C, Hara T, Hayakawa T, Hollnagel A, Ishiguro K, Iuliano A, Jakovcic K, Jollet C, Kamiscioglu C, Kamiscioglu M, Kim SH, Kitagawa N, Klicek B, Kodama K, Komatsu M, Kose U, Kreslo I, Laudisio F, Lauria A, Ljubicic A, Longhin A, Loverre P, Malenica M, Malgin A, Mandrioli G, Matsuo T, Matveev V, Mauri N, Medinaceli E, Meregaglia A, Mikado S, Miyanishi M, Mizutani F, Monacelli P, Montesi MC, Morishima K, Muciaccia MT, Naganawa N, Naka T, Nakamura M, Nakano T, Niwa K, Ogawa S, Okateva N, Olchevsky A, Ozaki K, Paoloni A, Paparella L, Park BD, Pasqualini L, Pastore A, Patrizii L, Pessard H, Pistillo C, Podgrudkov D, Polukhina N, Pozzato M, Pupilli F, Roda M, Roganova T, Rokujo H, Rosa G, Ryazhskaya O, Sadovsky A, Sato O, Schembri A, Shakiryanova I, Shchedrina T, Shibayama E, Shibuya H, Shiraishi T, Simone S, Sirignano C, Sirri G, Sotnikov A, Spinetti M, Stanco L, Starkov N, Stellacci SM, Stipcevic M, Strolin P, Takahashi S, Tenti M, Terranova F, Tioukov V, Tufanli S, Ustyuzhanin A, Vasina S, Vilain P, Voevodina E, Votano L, Vuilleumier JL, Wilquet G, Wonsak B, Yoon CS. Final Results of the OPERA Experiment on ν_{τ} Appearance in the CNGS Neutrino Beam. Phys Rev Lett 2018; 120:211801. [PMID: 29883136 DOI: 10.1103/physrevlett.120.211801] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/16/2018] [Indexed: 06/08/2023]
Abstract
The OPERA experiment was designed to study ν_{μ}→ν_{τ} oscillations in the appearance mode in the CERN to Gran Sasso Neutrino beam (CNGS). In this Letter, we report the final analysis of the full data sample collected between 2008 and 2012, corresponding to 17.97×10^{19} protons on target. Selection criteria looser than in previous analyses have produced ten ν_{τ} candidate events, thus reducing the statistical uncertainty in the measurement of the oscillation parameters and of ν_{τ} properties. A multivariate approach for event identification has been applied to the candidate events and the discovery of ν_{τ} appearance is confirmed with an improved significance level of 6.1σ. |Δm_{32}^{2}| has been measured, in appearance mode, with an accuracy of 20%. The measurement of the ν_{τ} charged-current cross section, for the first time with a negligible contamination from ν[over ¯]_{τ}, and the first direct evidence for the ν_{τ} lepton number are also reported.
Collapse
Affiliation(s)
- N Agafonova
- INR-Institute for Nuclear Research of the Russian Academy of Sciences, RUS-117312 Moscow, Russia
| | | | - A Anokhina
- SINP MSU-Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, RUS-119991 Moscow, Russia
| | - S Aoki
- Kobe University, J-657-8501 Kobe, Japan
| | - A Ariga
- Albert Einstein Center for Fundamental Physics, Laboratory for High Energy Physics (LHEP), University of Bern, CH-3012 Bern, Switzerland
| | - T Ariga
- Albert Einstein Center for Fundamental Physics, Laboratory for High Energy Physics (LHEP), University of Bern, CH-3012 Bern, Switzerland
- Faculty of Arts and Science, Kyushu University, J-819-0395 Fukuoka, Japan
| | - A Bertolin
- INFN Sezione di Padova, I-35131 Padova, Italy
| | - C Bozza
- Dipartimento di Fisica dell'Università di Salerno and "Gruppo Collegato" INFN, I-84084 Fisciano (Salerno), Italy
| | - R Brugnera
- INFN Sezione di Padova, I-35131 Padova, Italy
- Dipartimento di Fisica e Astronomia dell'Università di Padova, I-35131 Padova, Italy
| | - A Buonaura
- INFN Sezione di Napoli, I-80126 Napoli, Italy
- Dipartimento di Fisica dell'Università Federico II di Napoli, I-80126 Napoli, Italy
| | - S Buontempo
- INFN Sezione di Napoli, I-80126 Napoli, Italy
| | - M Chernyavskiy
- LPI-Lebedev Physical Institute of the Russian Academy of Sciences, RUS-119991 Moscow, Russia
| | - A Chukanov
- JINR-Joint Institute for Nuclear Research, RUS-141980 Dubna, Russia
| | - L Consiglio
- INFN Sezione di Napoli, I-80126 Napoli, Italy
| | - N D'Ambrosio
- INFN-Laboratori Nazionali del Gran Sasso, I-67010 Assergi (L'Aquila), Italy
| | - G De Lellis
- INFN Sezione di Napoli, I-80126 Napoli, Italy
- Dipartimento di Fisica dell'Università Federico II di Napoli, I-80126 Napoli, Italy
| | - M De Serio
- Dipartimento di Fisica dell'Università di Bari, I-70126 Bari, Italy
- INFN Sezione di Bari, I-70126 Bari, Italy
| | - P Del Amo Sanchez
- LAPP, Université Savoie Mont Blanc, CNRS/IN2P3, F-74941 Annecy-le-Vieux, France
| | - A Di Crescenzo
- INFN Sezione di Napoli, I-80126 Napoli, Italy
- Dipartimento di Fisica dell'Università Federico II di Napoli, I-80126 Napoli, Italy
| | | | - N Di Marco
- INFN-Laboratori Nazionali del Gran Sasso, I-67010 Assergi (L'Aquila), Italy
| | - S Dmitrievsky
- JINR-Joint Institute for Nuclear Research, RUS-141980 Dubna, Russia
| | - M Dracos
- IPHC, Université de Strasbourg, CNRS/IN2P3, F-67037 Strasbourg, France
| | - D Duchesneau
- LAPP, Université Savoie Mont Blanc, CNRS/IN2P3, F-74941 Annecy-le-Vieux, France
| | - S Dusini
- INFN Sezione di Padova, I-35131 Padova, Italy
| | - T Dzhatdoev
- SINP MSU-Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, RUS-119991 Moscow, Russia
| | - J Ebert
- Hamburg University, D-22761 Hamburg, Germany
| | - A Ereditato
- Albert Einstein Center for Fundamental Physics, Laboratory for High Energy Physics (LHEP), University of Bern, CH-3012 Bern, Switzerland
| | - J Favier
- LAPP, Université Savoie Mont Blanc, CNRS/IN2P3, F-74941 Annecy-le-Vieux, France
| | - R A Fini
- INFN Sezione di Bari, I-70126 Bari, Italy
| | - F Fornari
- INFN Sezione di Bologna, I-40127 Bologna, Italy
- Dipartimento di Fisica e Astronomia dell'Università di Bologna, I-40127 Bologna, Italy
| | - T Fukuda
- Nagoya University, J-464-8602 Nagoya, Japan
| | - G Galati
- INFN Sezione di Napoli, I-80126 Napoli, Italy
- Dipartimento di Fisica dell'Università Federico II di Napoli, I-80126 Napoli, Italy
| | - A Garfagnini
- INFN Sezione di Padova, I-35131 Padova, Italy
- Dipartimento di Fisica e Astronomia dell'Università di Padova, I-35131 Padova, Italy
| | - V Gentile
- GSSI-Gran Sasso Science Institute, I-40127 L'Aquila, Italy
| | - J Goldberg
- Department of Physics, Technion, IL-32000 Haifa, Israel
| | - S Gorbunov
- LPI-Lebedev Physical Institute of the Russian Academy of Sciences, RUS-119991 Moscow, Russia
| | - Y Gornushkin
- JINR-Joint Institute for Nuclear Research, RUS-141980 Dubna, Russia
| | - G Grella
- Dipartimento di Fisica dell'Università di Salerno and "Gruppo Collegato" INFN, I-84084 Fisciano (Salerno), Italy
| | - A M Guler
- METU-Middle East Technical University, TR-06800 Ankara, Turkey
| | | | - C Hagner
- Hamburg University, D-22761 Hamburg, Germany
| | - T Hara
- Kobe University, J-657-8501 Kobe, Japan
| | - T Hayakawa
- Nagoya University, J-464-8602 Nagoya, Japan
| | - A Hollnagel
- Hamburg University, D-22761 Hamburg, Germany
| | - K Ishiguro
- Nagoya University, J-464-8602 Nagoya, Japan
| | - A Iuliano
- INFN Sezione di Napoli, I-80126 Napoli, Italy
- Dipartimento di Fisica dell'Università Federico II di Napoli, I-80126 Napoli, Italy
| | - K Jakovcic
- Ruder Bošković Institute, HR-10002 Zagreb, Croatia
| | - C Jollet
- IPHC, Université de Strasbourg, CNRS/IN2P3, F-67037 Strasbourg, France
| | - C Kamiscioglu
- METU-Middle East Technical University, TR-06800 Ankara, Turkey
- Ankara University, TR-06560 Ankara, Turkey
| | - M Kamiscioglu
- METU-Middle East Technical University, TR-06800 Ankara, Turkey
| | - S H Kim
- Gyeongsang National University, 900 Gazwa-dong, Jinju 660-701, Korea
| | - N Kitagawa
- Nagoya University, J-464-8602 Nagoya, Japan
| | - B Klicek
- Center of Excellence for Advanced Materials and Sensing Devices, Ruder Bośković Institute, HR-10002 Zagreb, Croatia
| | - K Kodama
- Aichi University of Education, J-448-8542 Kariya (Aichi-Ken), Japan
| | - M Komatsu
- Nagoya University, J-464-8602 Nagoya, Japan
| | - U Kose
- INFN Sezione di Padova, I-35131 Padova, Italy
| | - I Kreslo
- Albert Einstein Center for Fundamental Physics, Laboratory for High Energy Physics (LHEP), University of Bern, CH-3012 Bern, Switzerland
| | - F Laudisio
- INFN Sezione di Padova, I-35131 Padova, Italy
- Dipartimento di Fisica e Astronomia dell'Università di Padova, I-35131 Padova, Italy
| | - A Lauria
- INFN Sezione di Napoli, I-80126 Napoli, Italy
- Dipartimento di Fisica dell'Università Federico II di Napoli, I-80126 Napoli, Italy
| | - A Ljubicic
- Ruder Bošković Institute, HR-10002 Zagreb, Croatia
| | - A Longhin
- INFN Sezione di Padova, I-35131 Padova, Italy
- Dipartimento di Fisica e Astronomia dell'Università di Padova, I-35131 Padova, Italy
| | - P Loverre
- INFN Sezione di Roma, I-00185 Roma, Italy
| | - M Malenica
- Ruder Bošković Institute, HR-10002 Zagreb, Croatia
| | - A Malgin
- INR-Institute for Nuclear Research of the Russian Academy of Sciences, RUS-117312 Moscow, Russia
| | - G Mandrioli
- INFN Sezione di Bologna, I-40127 Bologna, Italy
| | - T Matsuo
- Toho University, J-274-8510 Funabashi, Japan
| | - V Matveev
- INR-Institute for Nuclear Research of the Russian Academy of Sciences, RUS-117312 Moscow, Russia
| | - N Mauri
- INFN Sezione di Bologna, I-40127 Bologna, Italy
- Dipartimento di Fisica e Astronomia dell'Università di Bologna, I-40127 Bologna, Italy
| | - E Medinaceli
- INFN Sezione di Padova, I-35131 Padova, Italy
- Dipartimento di Fisica e Astronomia dell'Università di Padova, I-35131 Padova, Italy
| | - A Meregaglia
- IPHC, Université de Strasbourg, CNRS/IN2P3, F-67037 Strasbourg, France
| | - S Mikado
- Nihon University, J-275-8576 Narashino, Chiba, Japan
| | | | | | | | - M C Montesi
- INFN Sezione di Napoli, I-80126 Napoli, Italy
- Dipartimento di Fisica dell'Università Federico II di Napoli, I-80126 Napoli, Italy
| | | | - M T Muciaccia
- Dipartimento di Fisica dell'Università di Bari, I-70126 Bari, Italy
- INFN Sezione di Bari, I-70126 Bari, Italy
| | - N Naganawa
- Nagoya University, J-464-8602 Nagoya, Japan
| | - T Naka
- Nagoya University, J-464-8602 Nagoya, Japan
| | - M Nakamura
- Nagoya University, J-464-8602 Nagoya, Japan
| | - T Nakano
- Nagoya University, J-464-8602 Nagoya, Japan
| | - K Niwa
- Nagoya University, J-464-8602 Nagoya, Japan
| | - S Ogawa
- Toho University, J-274-8510 Funabashi, Japan
| | - N Okateva
- LPI-Lebedev Physical Institute of the Russian Academy of Sciences, RUS-119991 Moscow, Russia
| | - A Olchevsky
- JINR-Joint Institute for Nuclear Research, RUS-141980 Dubna, Russia
| | - K Ozaki
- Kobe University, J-657-8501 Kobe, Japan
| | - A Paoloni
- INFN-Laboratori Nazionali di Frascati dell'INFN, I-00044 Frascati (Roma), Italy
| | - L Paparella
- Dipartimento di Fisica dell'Università di Bari, I-70126 Bari, Italy
- INFN Sezione di Bari, I-70126 Bari, Italy
| | - B D Park
- Gyeongsang National University, 900 Gazwa-dong, Jinju 660-701, Korea
| | - L Pasqualini
- INFN Sezione di Bologna, I-40127 Bologna, Italy
- Dipartimento di Fisica e Astronomia dell'Università di Bologna, I-40127 Bologna, Italy
| | - A Pastore
- INFN Sezione di Bari, I-70126 Bari, Italy
| | - L Patrizii
- INFN Sezione di Bologna, I-40127 Bologna, Italy
| | - H Pessard
- LAPP, Université Savoie Mont Blanc, CNRS/IN2P3, F-74941 Annecy-le-Vieux, France
| | - C Pistillo
- Albert Einstein Center for Fundamental Physics, Laboratory for High Energy Physics (LHEP), University of Bern, CH-3012 Bern, Switzerland
| | - D Podgrudkov
- SINP MSU-Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, RUS-119991 Moscow, Russia
| | - N Polukhina
- LPI-Lebedev Physical Institute of the Russian Academy of Sciences, RUS-119991 Moscow, Russia
- MEPhI-Moscow Engineering Physics Institute, RUS-115409 Moscow, Russia
| | - M Pozzato
- INFN Sezione di Bologna, I-40127 Bologna, Italy
- Dipartimento di Fisica e Astronomia dell'Università di Bologna, I-40127 Bologna, Italy
| | - F Pupilli
- INFN Sezione di Padova, I-35131 Padova, Italy
| | - M Roda
- INFN Sezione di Padova, I-35131 Padova, Italy
- Dipartimento di Fisica e Astronomia dell'Università di Padova, I-35131 Padova, Italy
| | - T Roganova
- SINP MSU-Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, RUS-119991 Moscow, Russia
| | - H Rokujo
- Nagoya University, J-464-8602 Nagoya, Japan
| | - G Rosa
- INFN Sezione di Roma, I-00185 Roma, Italy
| | - O Ryazhskaya
- INR-Institute for Nuclear Research of the Russian Academy of Sciences, RUS-117312 Moscow, Russia
| | - A Sadovsky
- JINR-Joint Institute for Nuclear Research, RUS-141980 Dubna, Russia
| | - O Sato
- Nagoya University, J-464-8602 Nagoya, Japan
| | - A Schembri
- INFN-Laboratori Nazionali del Gran Sasso, I-67010 Assergi (L'Aquila), Italy
| | - I Shakiryanova
- INR-Institute for Nuclear Research of the Russian Academy of Sciences, RUS-117312 Moscow, Russia
| | - T Shchedrina
- LPI-Lebedev Physical Institute of the Russian Academy of Sciences, RUS-119991 Moscow, Russia
| | | | - H Shibuya
- Toho University, J-274-8510 Funabashi, Japan
| | | | - S Simone
- Dipartimento di Fisica dell'Università di Bari, I-70126 Bari, Italy
- INFN Sezione di Bari, I-70126 Bari, Italy
| | - C Sirignano
- INFN Sezione di Padova, I-35131 Padova, Italy
- Dipartimento di Fisica e Astronomia dell'Università di Padova, I-35131 Padova, Italy
| | - G Sirri
- INFN Sezione di Bologna, I-40127 Bologna, Italy
| | - A Sotnikov
- JINR-Joint Institute for Nuclear Research, RUS-141980 Dubna, Russia
| | - M Spinetti
- INFN-Laboratori Nazionali di Frascati dell'INFN, I-00044 Frascati (Roma), Italy
| | - L Stanco
- INFN Sezione di Padova, I-35131 Padova, Italy
| | - N Starkov
- LPI-Lebedev Physical Institute of the Russian Academy of Sciences, RUS-119991 Moscow, Russia
| | - S M Stellacci
- Dipartimento di Fisica dell'Università di Salerno and "Gruppo Collegato" INFN, I-84084 Fisciano (Salerno), Italy
| | - M Stipcevic
- Center of Excellence for Advanced Materials and Sensing Devices, Ruder Bośković Institute, HR-10002 Zagreb, Croatia
| | - P Strolin
- INFN Sezione di Napoli, I-80126 Napoli, Italy
- Dipartimento di Fisica dell'Università Federico II di Napoli, I-80126 Napoli, Italy
| | | | - M Tenti
- INFN Sezione di Bologna, I-40127 Bologna, Italy
| | - F Terranova
- Dipartimento di Fisica dell'Università di Milano-Bicocca, I-20126 Milano, Italy
| | - V Tioukov
- INFN Sezione di Napoli, I-80126 Napoli, Italy
| | - S Tufanli
- Albert Einstein Center for Fundamental Physics, Laboratory for High Energy Physics (LHEP), University of Bern, CH-3012 Bern, Switzerland
| | - A Ustyuzhanin
- INFN Sezione di Napoli, I-80126 Napoli, Italy
- HSE-National Research University Higher School of Economics, RUS-101000, Moscow, Russia
| | - S Vasina
- JINR-Joint Institute for Nuclear Research, RUS-141980 Dubna, Russia
| | - P Vilain
- IIHE, Université Libre de Bruxelles, B-1050 Brussels, Belgium
| | - E Voevodina
- INFN Sezione di Napoli, I-80126 Napoli, Italy
| | - L Votano
- INFN-Laboratori Nazionali di Frascati dell'INFN, I-00044 Frascati (Roma), Italy
| | - J L Vuilleumier
- Albert Einstein Center for Fundamental Physics, Laboratory for High Energy Physics (LHEP), University of Bern, CH-3012 Bern, Switzerland
| | - G Wilquet
- IIHE, Université Libre de Bruxelles, B-1050 Brussels, Belgium
| | - B Wonsak
- Hamburg University, D-22761 Hamburg, Germany
| | - C S Yoon
- Gyeongsang National University, 900 Gazwa-dong, Jinju 660-701, Korea
| |
Collapse
|
163
|
Yokoyama Y, Yamasaki Y, Taguchi M, Hirata Y, Takubo K, Miyawaki J, Harada Y, Asakura D, Fujioka J, Nakamura M, Daimon H, Kawasaki M, Tokura Y, Wadati H. Tensile-Strain-Dependent Spin States in Epitaxial LaCoO_{3} Thin Films. Phys Rev Lett 2018; 120:206402. [PMID: 29864291 DOI: 10.1103/physrevlett.120.206402] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/24/2017] [Indexed: 06/08/2023]
Abstract
The spin states of Co^{3+} ions in perovskite-type LaCoO_{3}, governed by the complex interplay between the electron-lattice interactions and the strong electron correlations, still remain controversial due to the lack of experimental techniques which can directly detect them. In this Letter, we revealed the tensile-strain dependence of spin states, i.e., the ratio of the high- and low-spin states, in epitaxial thin films and a bulk crystal of LaCoO_{3} via resonant inelastic soft x-ray scattering. A tensile strain as small as 1.0% was found to realize different spin states from that in the bulk.
Collapse
Affiliation(s)
- Y Yokoyama
- Institute for Solid State Physics, University of Tokyo, Chiba 277-8581, Japan
- Department of Physics, University of Tokyo, Tokyo 113-0033, Japan
| | - Y Yamasaki
- Department of Applied Physics and Quantum-Phase Electronics Center (QPEC), University of Tokyo, Hongo, Tokyo 113-8656, Japan
- RIKEN Center for Emergent Matter Science (CEMS), Wako 351-0198, Japan
- National Institute for Materials Science (NIMS), Tsukuba 305-0047, Japan
| | - M Taguchi
- Nara Institute of Science and Technology (NAIST), 8916-5, Takayama, Ikoma, Nara 630-0192, Japan
| | - Y Hirata
- Institute for Solid State Physics, University of Tokyo, Chiba 277-8581, Japan
- Department of Physics, University of Tokyo, Tokyo 113-0033, Japan
| | - K Takubo
- Institute for Solid State Physics, University of Tokyo, Chiba 277-8581, Japan
| | - J Miyawaki
- Institute for Solid State Physics, University of Tokyo, Chiba 277-8581, Japan
| | - Y Harada
- Institute for Solid State Physics, University of Tokyo, Chiba 277-8581, Japan
| | - D Asakura
- Research Institute for Energy Conservation, National Institute of Advance Industrial Science and Technology (AIST), Umezono 1-1-1, Tsukuba 305-8568, Japan
| | - J Fujioka
- Department of Applied Physics and Quantum-Phase Electronics Center (QPEC), University of Tokyo, Hongo, Tokyo 113-8656, Japan
| | - M Nakamura
- RIKEN Center for Emergent Matter Science (CEMS), Wako 351-0198, Japan
| | - H Daimon
- Nara Institute of Science and Technology (NAIST), 8916-5, Takayama, Ikoma, Nara 630-0192, Japan
| | - M Kawasaki
- Department of Applied Physics and Quantum-Phase Electronics Center (QPEC), University of Tokyo, Hongo, Tokyo 113-8656, Japan
- RIKEN Center for Emergent Matter Science (CEMS), Wako 351-0198, Japan
| | - Y Tokura
- Department of Applied Physics and Quantum-Phase Electronics Center (QPEC), University of Tokyo, Hongo, Tokyo 113-8656, Japan
- RIKEN Center for Emergent Matter Science (CEMS), Wako 351-0198, Japan
| | - H Wadati
- Institute for Solid State Physics, University of Tokyo, Chiba 277-8581, Japan
- Department of Physics, University of Tokyo, Tokyo 113-0033, Japan
| |
Collapse
|
164
|
Yang E, Sanchez I, Sekhon S, Beck K, Bhattarai S, Yan D, Chen H, Huang Z, Liu J, Stultz J, Nakamura M, Bhutani T, Rosenblum M, Liao W. 424 Immunologic response of T cells in plaque psoriasis to secukinumab. J Invest Dermatol 2018. [DOI: 10.1016/j.jid.2018.03.431] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
165
|
Nakamura M, Moosmann S, Krutmann J, Vogel C, Haarmann-Stemmann T, Morita A. 684 Aryl hydrocarbon receptor-dependent expression of aldo-keto reductase 1C3 in the pathogenesis of atopic dermatitis caused by air pollution. J Invest Dermatol 2018. [DOI: 10.1016/j.jid.2018.03.693] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
166
|
Nishi T, Itahashi K, Berg GPA, Fujioka H, Fukuda N, Fukunishi N, Geissel H, Hayano RS, Hirenzaki S, Ichikawa K, Ikeno N, Inabe N, Itoh S, Iwasaki M, Kameda D, Kawase S, Kubo T, Kusaka K, Matsubara H, Michimasa S, Miki K, Mishima G, Miya H, Nagahiro H, Nakamura M, Noji S, Okochi K, Ota S, Sakamoto N, Suzuki K, Takeda H, Tanaka YK, Todoroki K, Tsukada K, Uesaka T, Watanabe YN, Weick H, Yamakami H, Yoshida K. Spectroscopy of Pionic Atoms in ^{122}Sn(d,^{3}He) Reaction and Angular Dependence of the Formation Cross Sections. Phys Rev Lett 2018; 120:152505. [PMID: 29756883 DOI: 10.1103/physrevlett.120.152505] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/24/2017] [Revised: 02/07/2018] [Indexed: 06/08/2023]
Abstract
We observed the atomic 1s and 2p states of π^{-} bound to ^{121}Sn nuclei as distinct peak structures in the missing mass spectra of the ^{122}Sn(d,^{3}He) nuclear reaction. A very intense deuteron beam and a spectrometer with a large angular acceptance let us achieve a potential of discovery, which includes the capability of determining the angle-dependent cross sections with high statistics. The 2p state in a Sn nucleus was observed for the first time. The binding energies and widths of the pionic states are determined and found to be consistent with previous experimental results of other Sn isotopes. The spectrum is measured at finite reaction angles for the first time. The formation cross sections at the reaction angles between 0° and 2° are determined. The observed reaction-angle dependence of each state is reproduced by theoretical calculations. However, the quantitative comparison with our high-precision data reveals a significant discrepancy between the measured and calculated formation cross sections of the pionic 1s state.
Collapse
Affiliation(s)
- T Nishi
- Department of Physics, School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-0033 Tokyo, Japan
- Nishina Center for Accelerator-Based Science, RIKEN, 2-1 Hirosawa, Wako, 351-0198 Saitama, Japan
| | - K Itahashi
- Nishina Center for Accelerator-Based Science, RIKEN, 2-1 Hirosawa, Wako, 351-0198 Saitama, Japan
| | - G P A Berg
- Department of Physics and the Joint Institute for Nuclear Astrophysics Center for the Evolution of the Elements, University of Notre Dame, Notre Dame, Indiana 46556, USA
| | - H Fujioka
- Department of Physics, Kyoto University, Kitashirakawa-Oiwakecho, Sakyo-ku, Kyoto, 606-8502 Kyoto, Japan
| | - N Fukuda
- Nishina Center for Accelerator-Based Science, RIKEN, 2-1 Hirosawa, Wako, 351-0198 Saitama, Japan
| | - N Fukunishi
- Nishina Center for Accelerator-Based Science, RIKEN, 2-1 Hirosawa, Wako, 351-0198 Saitama, Japan
| | - H Geissel
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, Planckstrasse 1, D-64291 Darmstadt, Germany
| | - R S Hayano
- Department of Physics, School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-0033 Tokyo, Japan
| | - S Hirenzaki
- Department of Physics, Nara Women's University, Kita-Uoya Nishimachi, Nara, 630-8506 Nara, Japan
| | - K Ichikawa
- Department of Physics, School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-0033 Tokyo, Japan
| | - N Ikeno
- Department of Life and Environmental Agricultural Sciences, Faculty of Agriculture, Tottori University, 4-101 Koyamacho-Minami, Tottori, 680-8551 Tottori, Japan
| | - N Inabe
- Nishina Center for Accelerator-Based Science, RIKEN, 2-1 Hirosawa, Wako, 351-0198 Saitama, Japan
| | - S Itoh
- Department of Physics, School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-0033 Tokyo, Japan
| | - M Iwasaki
- Nishina Center for Accelerator-Based Science, RIKEN, 2-1 Hirosawa, Wako, 351-0198 Saitama, Japan
| | - D Kameda
- Nishina Center for Accelerator-Based Science, RIKEN, 2-1 Hirosawa, Wako, 351-0198 Saitama, Japan
| | - S Kawase
- Center for Nuclear Study, The University of Tokyo, 2-1 Hirosawa, Wako, 351-0198 Saitama, Japan
| | - T Kubo
- Nishina Center for Accelerator-Based Science, RIKEN, 2-1 Hirosawa, Wako, 351-0198 Saitama, Japan
| | - K Kusaka
- Nishina Center for Accelerator-Based Science, RIKEN, 2-1 Hirosawa, Wako, 351-0198 Saitama, Japan
| | - H Matsubara
- Center for Nuclear Study, The University of Tokyo, 2-1 Hirosawa, Wako, 351-0198 Saitama, Japan
| | - S Michimasa
- Center for Nuclear Study, The University of Tokyo, 2-1 Hirosawa, Wako, 351-0198 Saitama, Japan
| | - K Miki
- Department of Physics, School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-0033 Tokyo, Japan
| | - G Mishima
- Department of Physics, School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-0033 Tokyo, Japan
| | - H Miya
- Nishina Center for Accelerator-Based Science, RIKEN, 2-1 Hirosawa, Wako, 351-0198 Saitama, Japan
| | - H Nagahiro
- Department of Physics, Nara Women's University, Kita-Uoya Nishimachi, Nara, 630-8506 Nara, Japan
| | - M Nakamura
- Nishina Center for Accelerator-Based Science, RIKEN, 2-1 Hirosawa, Wako, 351-0198 Saitama, Japan
| | - S Noji
- Department of Physics, School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-0033 Tokyo, Japan
| | - K Okochi
- Department of Physics, School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-0033 Tokyo, Japan
| | - S Ota
- Center for Nuclear Study, The University of Tokyo, 2-1 Hirosawa, Wako, 351-0198 Saitama, Japan
| | - N Sakamoto
- Nishina Center for Accelerator-Based Science, RIKEN, 2-1 Hirosawa, Wako, 351-0198 Saitama, Japan
| | - K Suzuki
- Stefan Meyer Institute for Subatomic Physics, Austrian Academy of Sciences, Boltzmanngasse 3, A-1090 Vienna, Austria
| | - H Takeda
- Nishina Center for Accelerator-Based Science, RIKEN, 2-1 Hirosawa, Wako, 351-0198 Saitama, Japan
| | - Y K Tanaka
- Department of Physics, School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-0033 Tokyo, Japan
| | - K Todoroki
- Department of Physics, School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-0033 Tokyo, Japan
| | - K Tsukada
- Nishina Center for Accelerator-Based Science, RIKEN, 2-1 Hirosawa, Wako, 351-0198 Saitama, Japan
| | - T Uesaka
- Nishina Center for Accelerator-Based Science, RIKEN, 2-1 Hirosawa, Wako, 351-0198 Saitama, Japan
| | - Y N Watanabe
- Department of Physics, School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-0033 Tokyo, Japan
| | - H Weick
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, Planckstrasse 1, D-64291 Darmstadt, Germany
| | - H Yamakami
- Department of Physics, Kyoto University, Kitashirakawa-Oiwakecho, Sakyo-ku, Kyoto, 606-8502 Kyoto, Japan
| | - K Yoshida
- Nishina Center for Accelerator-Based Science, RIKEN, 2-1 Hirosawa, Wako, 351-0198 Saitama, Japan
| |
Collapse
|
167
|
Matsushita N, Nakamura M, Sasaki M, Yano S, Yoshimura M, Mizowaki T. EP-2042: Use of on-treatment EPID images to detect inter-fractional anatomical variations. Radiother Oncol 2018. [DOI: 10.1016/s0167-8140(18)32351-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
168
|
Hiroshima Y, Fukumitsu N, Ishida T, Nakamura M, Shimizu S, Sekino Y, Miyauchi D, Iizumi T, Miura K, Kanuma R, Tanaka K, Saito T, Takizawa D, Numajiri H, Onishi K, Mizumoto M, Aihara T, Ishikawa H, Okumura T, Tsuboi K, Sakurai H. PO-0770: Concurrent chemoradiotherapy using photon and proton for locally advanced pancreatic cancer. Radiother Oncol 2018. [DOI: 10.1016/s0167-8140(18)31080-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
169
|
Kai K, Ryu Y, Kamochi K, Nishioka A, Kubota Y, Nakamura M, Kimura S, Sueoka E, Aishima S. Synchronous mantle cell lymphoma and lung adenocarcinoma presenting in a pleural effusion: A rare tumour combination and a potential pitfall of cytodiagnosis. Cytopathology 2018; 29:400-402. [PMID: 29575128 DOI: 10.1111/cyt.12532] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/13/2017] [Indexed: 02/05/2023]
Affiliation(s)
- K Kai
- Department of Pathology, Saga University Hospital, Saga, Japan
| | - Y Ryu
- Department of Pathology, Saga University Hospital, Saga, Japan
| | - K Kamochi
- Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan
| | - A Nishioka
- Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan
| | - Y Kubota
- Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan
| | - M Nakamura
- Department of Pathology, Saga University Hospital, Saga, Japan
| | - S Kimura
- Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan
| | - E Sueoka
- Department of Clinical Laboratory Medicine, Faculty of Medicine, Saga University, Saga, Japan
| | - S Aishima
- Department of Pathology, Saga University Hospital, Saga, Japan.,Department of Pathology and Microbiology, Faculty of Medicine, Saga University, Saga, Japan
| |
Collapse
|
170
|
Hayano S, Fukui Y, Kawanabe N, Kono K, Nakamura M, Ishihara Y, Kamioka H. Role of the Inferior Alveolar Nerve in Rodent Lower Incisor Stem Cells. J Dent Res 2018. [DOI: 10.1177/0022034518758244] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023] Open
Abstract
In developing teeth, the sequential and reciprocal interactions between epithelial and mesenchymal tissues promote stem/progenitor cell differentiation. However, the origin of the stem/progenitor cells has been the subject of considerable debate. According to recent studies, mesenchymal stem cells originate from periarterial cells and are regulated by neurons in various organs. The present study examined the role of innervation in tooth development and rodent incisor stem/progenitor cell homeostasis. Rodent incisors continuously grow throughout their lives, and the lower incisors are innervated by the inferior alveolar nerve (IAN). In this study, we resected the IAN in adult rats, and the intact contralateral side served as a nonsurgical control. Sham control rats received the same treatment as the resected rats, except for the resection process. The extent of incisor eruption was measured, and both mesenchymal and epithelial stem/progenitor cells were visualized and compared between the IAN-resected and sham-operated groups. One week after surgery, the IAN-resected incisors exhibited a chalky consistency, and the eruption rate was decreased. Micro–computed tomography and histological analyses performed 4 wk after surgery revealed osteodentin formation, disorganized ameloblast layers, and reduced enamel thickness in the IAN-resected incisors. Immunohistochemical analysis revealed a reduction in the CD90- and LRIG1-positive mesenchymal cell ratio in the IAN-resected incisors. However, the p40-positive epithelial stem/progenitor cell ratio was comparable between the 2 groups. Thus, mesenchymal stem/progenitor cell homeostasis is more related to IAN innervation than to epithelial stem/progenitor cells. Furthermore, sensory nerve innervation influences subsequent incisor growth and formation.
Collapse
Affiliation(s)
- S. Hayano
- Department of Orthodontics, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
| | - Y. Fukui
- Department of Orthodontics, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
| | - N. Kawanabe
- Department of Orthodontics, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
| | - K. Kono
- Department of Orthodontics, Okayama University Hospital, Okayama, Japan
| | - M. Nakamura
- Department of Orthodontics, Okayama University Hospital, Okayama, Japan
| | - Y. Ishihara
- Department of Orthodontics, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
| | - H. Kamioka
- Department of Orthodontics, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
| |
Collapse
|
171
|
Tokuda E, Komatsu T, Sasaki S, Tsuboi K, Nakamura M, Iida M, Niwa T, Saito M, Hayashi SI. Abstract P4-03-12: Effects of PI3K inhibitors on endocrine-resistant cell lines and differences in the characteristics of ER positive breast cancer cells after acquired resistance to the inhibitors. Cancer Res 2018. [DOI: 10.1158/1538-7445.sabcs17-p4-03-12] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background
Mutations in phosphatidylinositol 3-kinase (PI3K), which encodes the catalytic subunit of PI3Kα, is one of the most frequent genomic alterations and is found in about 40% of estrogen receptor (ER)-positive, HER2 negative breast cancers. PIK3CA mutations promote the growth and proliferation of cancers via activation of the PI3K/mammalian target of rapamycin pathway and can mediate resistance to endocrine therapies in breast cancer. Although several clinical trials for PI3K inhibitors (PI3Kis) in ER-positive metastatic breast cancers are ongoing, the effects of PI3Kis on endocrine-resistant breast cancers with various characteristics and definitive biomarkers of PI3Kis are unclear. Using endocrine-resistant cells established in our laboratory, we evaluated the efficacy of PI3Ki in these cell lines and identified the characteristics associated with acquired resistance to PI3Kis in endocrine-resistant cells.
Results
Long-term estrogen deprivation-resistant (EDR) cell lines and fulvestrant-resistant cell lines (MFR and TFR) were established from MCF-7 and T-47D cells in our previous studies. These cell lines showed different ER expression levels, including high expression (EDR-1), low expression (EDR-2, -3), or no expression (MFR, TFR); all of these cell lines had the same PIK3CA mutations as the parental cell lines. The pan-class1 PI3Ki buparlisib (BKM120) and α-specific PI3K inhibitor alpelisib (BYL719) inhibited the proliferation of endocrine-resistant cell lines when compared with their parental cells. Among endocrine-resistant cells, MFR cells were dramatically inhibited by PI3Kis. Colony formation assays indicated that MFR cells were more sensitive to PI3Kis than other cells lines. Next, we established PI3Ki- and everolimus-resistant cell lines from EDR-1, EDR-2, and MFR cells using BKM120, BYL719, and everolimus. Analysis of the time required to generate resistant cells showed that MFR cells required twice as long to acquire resistance compared with EDR cells. Furthermore, the time required to acquire resistance to BYL719 was shorter than that for BKM120. BYL719-resistant (BYL-R) cells were effectively inhibited by BKM120 to a degree similar to that of parental cells; however, BYL-R cells lost sensitivity to BYL719 and everolimus. Evelolimus-resistant (EVE-R) cells were also the same. In contrast, BKM120-resistant (BKM-R) cells showed less sensitivity to BKM120, BYL719, and everolimus. In other words, the pan-PI3Ki BKM120 was able to inhibit the growth of BYL-R and EVE-R cells, whereas BYL719 and everolimus were not able to inhibit BKM-R cells sufficiently. In addition, there were no changes in ER expression in EDR-1, EDR-2, and MFR cells exposed to PI3Kis for 1 h. Interestingly, ER expression on EDR-2 cells with acquired resistance to PI3Kis was increased compared with that in parental cells.
Conclusion
Our findings showed that PI3Kis exhibited remarkable efficacy in all types of EDR cells, particularly in fulvestrant-resistant cell lines. In PI3Ki- and everolimus-resistant cell lines, BKM120 and BYL719 showed different effects, and BYL719 and everolimus may exhibit cross-resistance. Furthermore, PI3Kis were likely to change the expression of ER.
Citation Format: Tokuda E, Komatsu T, Sasaki S, Tsuboi K, Nakamura M, Iida M, Niwa T, Saito M, Hayashi S-I. Effects of PI3K inhibitors on endocrine-resistant cell lines and differences in the characteristics of ER positive breast cancer cells after acquired resistance to the inhibitors [abstract]. In: Proceedings of the 2017 San Antonio Breast Cancer Symposium; 2017 Dec 5-9; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2018;78(4 Suppl):Abstract nr P4-03-12.
Collapse
Affiliation(s)
- E Tokuda
- Tohoku University Graduate School of Medicine, Sendai, Japan; Juntendo University Hospital, Tokyo, Japan
| | - T Komatsu
- Tohoku University Graduate School of Medicine, Sendai, Japan; Juntendo University Hospital, Tokyo, Japan
| | - S Sasaki
- Tohoku University Graduate School of Medicine, Sendai, Japan; Juntendo University Hospital, Tokyo, Japan
| | - K Tsuboi
- Tohoku University Graduate School of Medicine, Sendai, Japan; Juntendo University Hospital, Tokyo, Japan
| | - M Nakamura
- Tohoku University Graduate School of Medicine, Sendai, Japan; Juntendo University Hospital, Tokyo, Japan
| | - M Iida
- Tohoku University Graduate School of Medicine, Sendai, Japan; Juntendo University Hospital, Tokyo, Japan
| | - T Niwa
- Tohoku University Graduate School of Medicine, Sendai, Japan; Juntendo University Hospital, Tokyo, Japan
| | - M Saito
- Tohoku University Graduate School of Medicine, Sendai, Japan; Juntendo University Hospital, Tokyo, Japan
| | - S-I Hayashi
- Tohoku University Graduate School of Medicine, Sendai, Japan; Juntendo University Hospital, Tokyo, Japan
| |
Collapse
|
172
|
Iida M, Nakamura M, Tokuda E, Niwa T, Ishida T, Hayashi SI. Abstract P6-04-02: CDK6 might be a key factor for efficacy of CDK4/6 inhibitor and the hormone sensitivity following acquired resistance. Cancer Res 2018. [DOI: 10.1158/1538-7445.sabcs17-p6-04-02] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: CDK4/6 inhibitors have received FDA breakthrough therapy designation as 1st line treatment for advanced estrogen receptor positive breast cancer patients. However, the benefit offered by CDK4/6 inhibitors is individually different and furthermore acquired resistance to the drugs is monumental challenges. It is urgent need to search for the biomarker and understand the drug sensitivity and its alteration after acquired resistance.
Results: To identify the efficacy of CDK4/6 inhibitors, we assessed IC50 of ribociclib in several cell lines. Luminal cell lines (MCF-7, T-47D) exhibited lower ribociclib IC50 than HER-2 (SK-BR-3) and triple negative cell lines (MDA-MB-231, BT-20). Immunoblot analysis of Luminal cell lines showed extremely lower levels of CDK6 compared with others. CDK6-transfected MCF-7 by means of expression vector reduced the sensitivity equivalent to MDA-MB-231 not only to ribociclib but also to palbociclib and abemaciclib. Protein level of ERα in CDK6-transfected MCF-7 stayed unchanged and fulvestrant sensitivity was unaltered as well.
Subsequently, we detect the efficacy of ribociclib in hormone resistant cell lines. Estrogen deprivation-resistant (EDR) cells (EDR1:ER-positive, EDR2:ER-negative) and fulvestrant resistance (MFR) cells (loss of ER expression) established from MCF-7 maintained ribocilib sensitivity to the same degree with MCF-7. No marked difference in IC50 was observed between EDR1/2 and MFR, and CDK6 expressions were comparable to MCF-7. These results suggest that high level of CDK6 expression weaken the sensitivity to CDK4/6 inhibitors. The inhibitors would provide more effective benefits to tumors expressing lower level of CDK6 than the higher, independent of hormone sensitivity.
To understand the characteristics in acquired resistance, ribociclib resistant cell lines (RIBR1/2) were established from EDR1 by long-term culture with ribociclib. RIBR designed lower level of p21, p27 and ERα by immunoblot analysis. EDR1 were promoted cell growth by estrogen addition, while RIBR were not. Further, ER activity of RIBR was intensely decreased, and mRNA levels of the ER target genes, PgR and EGR3 were also decreased. Therefore, the responsiveness to tamoxifen and fulvestrant were lost. On the other hand, PI3K inhibitor and mTOR inhibitor suppressed cell growth to the same extent as EDR1, suggesting that RIBR were reduced ER dependence and remain reliant on PI3K/Akt/mTOR pathway.
Conclusion: The possibility of CDK6 as a biomarker is corroborated by the finding that low level of CDK6 expression is positively correlated with the efficacy of CDK4/6 inhibitor. Further ER dependence had decreased after acquired CDK4/6 inhibitor resistance whereas the dependence on PI3K/Akt/mTOR pathway still remain, indicating the inhibition of PI3K/Akt/mTOR pathway would be amenable to therapeutic target.
Citation Format: Iida M, Nakamura M, Tokuda E, Niwa T, Ishida T, Hayashi S-I. CDK6 might be a key factor for efficacy of CDK4/6 inhibitor and the hormone sensitivity following acquired resistance [abstract]. In: Proceedings of the 2017 San Antonio Breast Cancer Symposium; 2017 Dec 5-9; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2018;78(4 Suppl):Abstract nr P6-04-02.
Collapse
Affiliation(s)
- M Iida
- Graduate School of Medicine, Tohoku University, Sendai, Japan
| | - M Nakamura
- Graduate School of Medicine, Tohoku University, Sendai, Japan
| | - E Tokuda
- Graduate School of Medicine, Tohoku University, Sendai, Japan
| | - T Niwa
- Graduate School of Medicine, Tohoku University, Sendai, Japan
| | - T Ishida
- Graduate School of Medicine, Tohoku University, Sendai, Japan
| | - S-I Hayashi
- Graduate School of Medicine, Tohoku University, Sendai, Japan
| |
Collapse
|
173
|
Abstract
Abstract:A technique based on bispectra and cross-bispectra is described for estimating waveform and latency from a set of noisy signals with variable latency. Waveform estimation is performed by averaging bispectra of observed noisy signals. Latency estimation is performed by using the product function of a function derived from the cross-bispectrum and the cross-correlation. The method is numerically assessed by simulations, using a signal with uniformly distributed latency and computer-generated noise sequences.
Collapse
|
174
|
Murakami A, Nakamura M, Kaneko S, Lin WL, Dickson DW, Kusaka H. Aberrant accumulation of ErbB4 in progressive supranuclear palsy. Neuropathol Appl Neurobiol 2018; 44:563-573. [PMID: 29319907 DOI: 10.1111/nan.12460] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2017] [Accepted: 12/28/2017] [Indexed: 11/29/2022]
Abstract
AIMS The human epidermal growth factor receptor family consists of four members that belong to the ErbB lineage of proteins (ErbB1-4). Neuregulin-1 (NRG1)/ErbB signalling regulates brain development and function. Abnormalities in this signalling have been implicated in the aetiology or development of neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis. So, we aimed at investigating whether the expression of NRG1 or ErbB proteins are altered in progressive supranuclear palsy (PSP). METHODS The brains of 10 PSP and six control patients were investigated by immunohistochemical analysis. RESULTS Whereas C-terminal ErbB4 immunoreacitivity was partially but distinctly present in the cytoplasm and/or in the nucleus of neurons in control patients, it was rarely observed in the neuronal nuclei in PSP patients. In contrast, neurofibrillary tangles, coiled bodies and threads were robustly immunoreactive for C-terminal ErbB4 in PSP. Double immunofluorescence for C-terminal ErbB4 and phospho-tau revealed co-localization of these proteins within neuronal and glial inclusions. To the contrary, there was no difference in the subcellular localization of NRG1, ErbB1, ErbB2, and N-terminal ErbB4 between control and PSP patients. These proteins were localized in the cytoplasm of neurons. CONCLUSIONS Our present results suggest that NRG1/ErbB4 signalling could be an important event in the pathogenesis of PSP.
Collapse
Affiliation(s)
- A Murakami
- Department of Neurology, Kansai Medical University, Hirakata, Japan
| | - M Nakamura
- Department of Neurology, Kansai Medical University, Hirakata, Japan
| | - S Kaneko
- Department of Neurology, Kansai Medical University, Hirakata, Japan
| | - W-L Lin
- Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA
| | - D W Dickson
- Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA
| | - H Kusaka
- Department of Neurology, Kansai Medical University, Hirakata, Japan
| |
Collapse
|
175
|
Amao Y, Fujimura M, Miyazaki M, Tadokoro A, Nakamura M, Shuto N. A visible-light driven electrochemical biofuel cell with the function of CO2conversion to formic acid: coupled thylakoid from microalgae and biocatalyst immobilized electrodes. NEW J CHEM 2018. [DOI: 10.1039/c8nj01118d] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
A new visible-light driven electrochemical biofuel cell consisting of the thylakoid membrane of microalgae immobilized on a TiO2layer electrode as a photoanode, a formate dehydrogenase/viologen co-immobilized electrode as a cathode, and a CO2-saturated buffer solution as the redox electrolyte, was developed.
Collapse
Affiliation(s)
- Y. Amao
- Advanced Research Institute for Natural Science and Technology
- Osaka City University
- Osaka 558-8585
- Japan
- Research Center for Artificial Photosynthesis
| | - M. Fujimura
- Advanced Research Institute for Natural Science and Technology
- Osaka City University
- Osaka 558-8585
- Japan
- Precursory Research for Embryonic Science and Technology (PRESTO)
| | - M. Miyazaki
- Advanced Research Institute for Natural Science and Technology
- Osaka City University
- Osaka 558-8585
- Japan
- Precursory Research for Embryonic Science and Technology (PRESTO)
| | - A. Tadokoro
- Precursory Research for Embryonic Science and Technology (PRESTO)
- Japan Science and Technology Agency
- Saitama 332-0012
- Japan
- Department of Applied Chemistry
| | - M. Nakamura
- Precursory Research for Embryonic Science and Technology (PRESTO)
- Japan Science and Technology Agency
- Saitama 332-0012
- Japan
- Department of Applied Chemistry
| | - N. Shuto
- Precursory Research for Embryonic Science and Technology (PRESTO)
- Japan Science and Technology Agency
- Saitama 332-0012
- Japan
- Department of Applied Chemistry
| |
Collapse
|
176
|
Kawamoto Y, Yuki S, Meguro T, Hatanaka K, Uebayashi M, Iwanaga I, Nakamura M, Eto K, Okuda H, Abe M, Aonuma A, Abe N, Sato A, Nakatsumi H, Muranaka T, Yagisawa M, Oba K, Sakata Y, Sakamoto N, Komatsu Y. HGCSG 1201: Phase II study of trastuzumab with irinotecan in HER2-positive metastatic or advanced gastric cancer patients previously treated with trastuzumab. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx660.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
177
|
Kawamoto M, Onishi H, Yamasaki A, Nakamura M. C4orf47 contributes to the induction of malignant phenotypes in pancreatic cancer. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx660.043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
178
|
Nakamura K, Nakamura M, Onikubo T. Is highly concentrated potassium preparation necessary for cisplatin administration? Ann Oncol 2017. [DOI: 10.1093/annonc/mdx676.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
179
|
Nakamura M, Onozawa M, Motegi A, Hojo H, Zenda S, Nakamura N, Udagawa H, Kirita K, Matsumoto S, Umemura S, Yoh K, Niho S, Goto K, Akimoto T. P3.14-001 Impact of PCI on Prognosis of LD-SCLC Through Pattern of Brain Metastases as a First Recurrence Site. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.1774] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
180
|
Hirano S, Naka G, Takeda Y, Iikura M, Hiroishi T, Shikano K, Yanagisawa A, Hayama N, Fujita T, Amano H, Nakamura M, Nakamura S, Tabeta H, Sugiyama H. P2.03-005 Overall Survival Results from a Prospective, Multicenter Phase II Trial of Low-Dose Erlotinib as Maintenance in NSCLC Harboring EGFR Mutation. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.1256] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
181
|
Chijiwa T, Komura D, Haraguchi M, Noguchi A, Sato H, Ito H, Nakayama H, Katayama M, Miyao N, Suemizu H, Nakamura Y, Furukawa D, Moriya T, Isagawa T, Katoh H, Ishikawa S, Nakamura M, Miyagi Y. The possibility of personalized chemotherapy for non-small cell lung cancer using interactome analyses of PDX/NOG models. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx671.037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
182
|
Miyagishima T, Yuki S, Muranaka T, Tsuji Y, Ota Y, Hatanaka K, Okuda H, Sasaki T, Dazai M, Konno J, Nakamura M, Ohta T, Honda T, Ishiguro A, Muto O, Kato S, Sato A, Abe M, Sakata Y, Komatsu Y. Analysis of tumor location: A retrospective trial for evaluating the safety and efficacy of regorafenib for patients with metastatic colorectal cancer: HGCSG1401. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx659.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
183
|
Takeda K, Kou I, Kawakami N, Yasuhiko Y, Ogura Y, Imagawa E, Miyake N, Matsumoto N, Sudo H, Kotani T, Nakamura M, Matsumoto M, Watanabe K, Ikegawa S. Response to Lefebvre et al. Clin Genet 2017; 92:563-564. [PMID: 28990171 DOI: 10.1111/cge.13011] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2017] [Revised: 02/23/2017] [Accepted: 03/06/2017] [Indexed: 11/28/2022]
Abstract
Congenital scoliosis (CS) is a common vertebral malformation with incidence of up to 1 of 1000 births worldwide. Recently, TBX6 has been reported as the first disease gene for CS: about 10% of CS patients are compound heterozygotes of rare null mutations and a common haplotype composed by 3 SNPs in TBX6. Lefebvre et al in this journal reported that 2 patients with spondylocostal dysostosis (SCD), a rare skeletal dysplasia affecting spine and ribs also have TBX6 mutations: 1 carried the microdeletion and a rare missense variant, and another 2 rare missense variants. We investigated the pathogenicity of the 3 missense variants in SCD by a luciferase assay. The results were negative for the proposal of Lefebvre et al. We consider these 2 SCD patients are more probably compound heterozygotes of null mutations and a common risk haplotype just as CS patients with TBX6 mutations.
Collapse
Affiliation(s)
- K Takeda
- Laboratory of Bone and Joint Diseases, Center for Integrative Medical Sciences, RIKEN, Tokyo, Japan.,Department of Orthopaedic Surgery, Keio University School of Medicine, Tokyo, Japan
| | - I Kou
- Laboratory of Bone and Joint Diseases, Center for Integrative Medical Sciences, RIKEN, Tokyo, Japan
| | - N Kawakami
- Department of Orthopaedic Surgery, Meijo Hospital, Nagoya, Japan
| | - Y Yasuhiko
- Division of Cellular and Molecular Toxicology, National Institute of Health Sciences, Tokyo, Japan
| | - Y Ogura
- Laboratory of Bone and Joint Diseases, Center for Integrative Medical Sciences, RIKEN, Tokyo, Japan.,Department of Orthopaedic Surgery, Keio University School of Medicine, Tokyo, Japan
| | - E Imagawa
- Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan
| | - N Miyake
- Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan
| | - N Matsumoto
- Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan
| | - H Sudo
- Department of Advanced Medicine for Spine and Spinal Cord Disorders, Hokkaido University Graduate School of Medicine, Sapporo, Japan
| | - T Kotani
- Department of Orthopaedic Surgery, Seirei Sakura Citizen Hospital, Sakura, Japan
| | | | - M Nakamura
- Department of Orthopaedic Surgery, Keio University School of Medicine, Tokyo, Japan
| | - M Matsumoto
- Department of Orthopaedic Surgery, Keio University School of Medicine, Tokyo, Japan
| | - K Watanabe
- Department of Orthopaedic Surgery, Keio University School of Medicine, Tokyo, Japan
| | - S Ikegawa
- Laboratory of Bone and Joint Diseases, Center for Integrative Medical Sciences, RIKEN, Tokyo, Japan
| |
Collapse
|
184
|
Yasuda K, Fukuda S, Nakamura M, Takata M, Kuwata Y, Sainouchi M, Kawarazaki S, Murase N, Ohtani R, Aoki T, Yonemoto N, Akao M, Tsukahata T. Predictors for cardioembolic stroke in Japanese patients with atrial fibrillation: The Fushimi AF Registry. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.3176] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
185
|
Fujii K, Mukumoto N, Nakamura K, Nakamura M, Takayama K, Mizowaki T. Evaluation of Knowledge-Based Versus Manual Treatment Planning of Whole-Pelvic Volumetric Modulated Arc Therapy With Simultaneous Integrated Boost for Node-Positive Prostate Cancer. Int J Radiat Oncol Biol Phys 2017. [DOI: 10.1016/j.ijrobp.2017.06.2195] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
186
|
Kuwata Y, Yoshinaga K, Matsuhashi M, Murase N, Ohtani R, Sainouchi M, Takata M, Masuda Y, Nakamura M. Disorganization of alpha-band networks in the hemisphere of the seizure FOCI revealed by functional connectivity analysis. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.3754] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
187
|
Oki M, Kaneko S, Morise S, Takenouchi N, Hashizume T, Tsuge A, Nakamura M, Wate R, Kusaka H. Zonisamide ameliorates levodopa-induced dyskinesia and reduces expression of striatal genes in Parkinson model rats. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.1675] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
188
|
Rolfes K, Nakamura M, Meller S, Homey B, Krutmann J, Haarmann-Stemmann T. 636 The tryptophan photoproduct 6-formylindolo[3,2-b]carbazole sensitizes keratinocytes to UVA-induced apoptosis: Clues for a cytoprotective role of the aryl hydrocarbon receptor. J Invest Dermatol 2017. [DOI: 10.1016/j.jid.2017.07.312] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
189
|
Nakamura M, Nishikawa R, Hashimoto N, Ishihara T, Uezono H, Harada A, Mayahara H, Ejima Y, Nishimura H. Dosimetric Parameters Predicting Local Failure after Stereotactic Body Radiation Therapy Using the Robotic Radiosurgery System for Oligometastatic Lesions in the Lung and Liver. Int J Radiat Oncol Biol Phys 2017. [DOI: 10.1016/j.ijrobp.2017.06.1760] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
190
|
Nakamura M, Moosmann S, Krutmann J, Vogel C, Haarmann-Stemmann T. 129 Aryl hydrocarbon receptor (AHR)-dependent expression of aldo-keto reductase (AKR) 1C3 in the lesions of atopic dermatitis. J Invest Dermatol 2017. [DOI: 10.1016/j.jid.2017.07.439] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
191
|
Araki M, Nakamura M, Sato W, Takahashi Y, Yamamura T. Potential benefits of the anti-IL-6 receptor antibody tocilizumab in multiple sclerosis patients with high plasmablast frequency. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.395] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
192
|
Miyazaki Y, Niino M, Takahashi E, Fukazawa T, Amino I, Nakano F, Nakamura M, Akimoto S, Minami N, Fujiki N, Doi S, Kikuchi S. B cell-activating factor of the TNF family expands circulating transitional B cells in multiple sclerosis patients treated with fingolimod. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.2224] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
193
|
Ohtani R, Nakamura M, Murase N, Sainouchi M, Kuwata Y, Takata M, Masuda Y, Kawabata Y, Nirengi S, Tsukahara T, Sakane N. Pre-treatment blood pressure is the predictor for hemorrhagic infarction after intravenous rt-PA. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.1801] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
194
|
Tashiro S, Nishimura S, Iwai H, Sugai K, Shinozaki M, Iwanami A, Toyama Y, Liu M, Okano H, Nakamura M. Functional recovery secondary to neural stem/progenitor cells transplantation combined with treadmill training in mice with chronic spinal cord injury. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.036] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
195
|
Kunieda T, Miyake K, Sakamoto H, Iwasaki Y, Fujita K, Nakamura M, Kaneko S, Kusaka H. Leptomeningeal collaterals strongly correlate with reduced CVR measured by acetazolamide-challenged SPECT using a stereotactic extraction estimation analysis in patients with internal carotid artery stenosis. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.2260] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
196
|
Nakamura M, Sawada Y, Mashima E, Kubo R, Yamaguchi T, Haruyama S, Yoshioka M, Okada E. 422 Galectin-7 suppresses the erythema and cytokine productions in Nc/Nga mice, an atopic dermatitis model. J Invest Dermatol 2017. [DOI: 10.1016/j.jid.2017.07.618] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
197
|
Suzuki G, Nakamura M, Michinaka C, Tue N, Handa H, Takigami H. Dioxin-like activity of brominated dioxins as individual compounds or mixtures in in vitro reporter gene assays with rat and mouse hepatoma cell lines. Toxicol In Vitro 2017; 44:134-141. [DOI: 10.1016/j.tiv.2017.06.025] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2017] [Revised: 05/17/2017] [Accepted: 06/23/2017] [Indexed: 10/19/2022]
|
198
|
Matsushita M, Ozawa K, Suzuki T, Nakamura M, Nakano N, Kanchi S, Ichikawa D, Matsuki E, Sakurai M, Karigane D, Kasahara H, Tsukamoto N, Shimizu T, Mori T, Nakajima H, Okamoto S, Kawakami Y, Hattori Y. CXorf48 is a potential therapeutic target for achieving treatment-free remission in CML patients. Blood Cancer J 2017; 7:e601. [PMID: 28862699 PMCID: PMC5709753 DOI: 10.1038/bcj.2017.84] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2017] [Accepted: 07/24/2017] [Indexed: 12/19/2022] Open
Abstract
Although the introduction of tyrosine kinase inhibitors (TKIs) has improved overall survival of patients with chronic myeloid leukemia (CML), about half of the patients eventually relapse after cessation of TKIs. In contrast, the remainder of the patients maintain molecular remission without TKIs, indicating that the patients' immune system could control proliferation of TKI-resistant leukemic stem cells (LSCs). However, the precise mechanism of immunity against CML-LSCs is not fully understood. We have identified a novel immune target, CXorf48, expressed in LSCs of CML patients. Cytotoxic T cells (CTLs) induced by the epitope peptide derived from CXorf48 recognized CD34+CD38- cells obtained from the bone marrow of CML patients. We detected CXorf48-specific CTLs in the peripheral blood mononuclear cells from CML patients who have discontinued imatinib after maintaining complete molecular remission for more than 2 years. Significantly, the relapse rate of CXorf48-specific CTL-negative patients was 63.6%, compared to 0% in CXorf48-specific CTL-positive patients. These results indicate that CXorf48 could be a promising therapeutic target of LSCs for immunotherapy to obtain durable treatment-free remission in CML patients.
Collapse
Affiliation(s)
- M Matsushita
- Division of Clinical Physiology and Therapeutics, Keio University, Faculty of Pharmacy, Shiabakoen, Minato-ku, Tokyo, Japan
| | - K Ozawa
- Division of Clinical Physiology and Therapeutics, Keio University, Faculty of Pharmacy, Shiabakoen, Minato-ku, Tokyo, Japan
| | - T Suzuki
- Division of Clinical Physiology and Therapeutics, Keio University, Faculty of Pharmacy, Shiabakoen, Minato-ku, Tokyo, Japan
| | - M Nakamura
- Division of Clinical Physiology and Therapeutics, Keio University, Faculty of Pharmacy, Shiabakoen, Minato-ku, Tokyo, Japan
| | - N Nakano
- Division of Clinical Physiology and Therapeutics, Keio University, Faculty of Pharmacy, Shiabakoen, Minato-ku, Tokyo, Japan
| | - S Kanchi
- Division of Clinical Physiology and Therapeutics, Keio University, Faculty of Pharmacy, Shiabakoen, Minato-ku, Tokyo, Japan
| | - D Ichikawa
- Division of Clinical Physiology and Therapeutics, Keio University, Faculty of Pharmacy, Shiabakoen, Minato-ku, Tokyo, Japan
| | - E Matsuki
- Division of Hematology, Department of Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan
| | - M Sakurai
- Division of Hematology, Department of Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan
| | - D Karigane
- Division of Hematology, Department of Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan
| | - H Kasahara
- Division of Hematology, Department of Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan
| | - N Tsukamoto
- Division of Cellular Signaling, Institute for Advanced Medical Research, Keio University, School of Medicine, Shinjuku-ku, Tokyo, Japan
| | - T Shimizu
- Division of Hematology, Department of Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan
| | - T Mori
- Division of Hematology, Department of Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan
| | - H Nakajima
- Division of Hematology, Department of Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.,Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Kanazawa-ku, Yokohama, Japan
| | - S Okamoto
- Division of Hematology, Department of Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan
| | - Y Kawakami
- Division of Cellular Signaling, Institute for Advanced Medical Research, Keio University, School of Medicine, Shinjuku-ku, Tokyo, Japan
| | - Y Hattori
- Division of Clinical Physiology and Therapeutics, Keio University, Faculty of Pharmacy, Shiabakoen, Minato-ku, Tokyo, Japan
| |
Collapse
|
199
|
Ichikawa W, Mogushi K, Lenz HJ, Zhang W, Tsuji A, Takahashi T, Denda T, Shimada K, Kochi M, Nakamura M, Kotaka M, Segawa Y, Lafleur B, Luecke J, Thompson D, Moran M, Astrow S, Hsiang J, Fujii M, Sunakawa Y. Tumor sidedness and enriched gene groups for efficacy of 1st-line cetuximab (cet) treatment in metastatic colorectal cancer (mCRC). Ann Oncol 2017. [DOI: 10.1093/annonc/mdx393.114] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
200
|
Kobayashi K, Nakachi I, Naoki K, Oyamada Y, Nakamura M, Inoue T, Tateno H, Sakamaki F, Sayama K, Terashima T, Koh H, Arai D, Yasuda H, Kawada I, Soejima K, Betsuyaku T. Practical effectiveness efficacy and safety of nivolumab for advanced non-small cell lung cancer: A retrospective multicenter analysis. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx380.026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|